As someone with asthma, this development in AI definitely caught my interest:
Insilico Medicine has developed a new drug for Idiopathic Pulmonary Fibrosis (IPF) using AI, which significantly speeds up the drug discovery process.
Using AI, they developed the drug ISM001-055 in record time鈥攗nder 30 months, compared to traditional drug development that often takes years.
Their drug, ISM001-055, recently showed promising results in clinical trials, improving lung function in IPF patients. This is a major step forward in AI-driven healthcare, demonstrating how AI can revolutionize treatments for complex diseases. 馃К
Check out more details here.